Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Stern

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Investigative Dermatology|January 25, 2003
Assessing the safety of immunologic modifiers for the treatment of chronic disease: the psoriasis paradigmRobert S Stern
Archives of Dermatology|September 20, 2006
Lymphoma risk in psoriasis: results of the PUVA follow-up studyRobert S Stern
Academic Medicine : Journal of the Association of American Medical Colleges|January 15, 2002
Medicare reimbursement policy and teaching physicians' behavior in hospital clinics: the changes of 1996Robert S Stern
The New England Journal of Medicine|February 1, 2002
Bullous pemphigoid therapy -- think globally, act locallyRobert S Stern
NEJM Evidence|November 5, 2025
Oral Psoriasis Therapy - For Whom and at What Cost and Risk?Robert S Stern
Journal of the American Academy of Dermatology|January 24, 2012
The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective studyRobert S Stern,
Health News (Waltham, Mass.)|July 9, 2004
Questions & answers. Of all the treatments that promise to improve the appearance of aging skin, which ones have been medically proven to actually work?Robert S Stern
The New England Journal of Medicine|April 9, 2004
Clinical practice. Treatment of photoagingRobert S Stern
The Journal of Investigative Dermatology. Symposium Proceedings|April 16, 2004
Dermatologists and office-based care of dermatologic disease in the 21st centuryRobert S Stern
Pharmacoepidemiology and Drug Safety|January 13, 2005
Utilization of hospital and outpatient care for adverse cutaneous reactions to medicationsRobert S Stern
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Investigative Dermatology|January 25, 2003
Assessing the safety of immunologic modifiers for the treatment of chronic disease: the psoriasis paradigmRobert S Stern
Archives of Dermatology|September 20, 2006
Lymphoma risk in psoriasis: results of the PUVA follow-up studyRobert S Stern
Academic Medicine : Journal of the Association of American Medical Colleges|January 15, 2002
Medicare reimbursement policy and teaching physicians' behavior in hospital clinics: the changes of 1996Robert S Stern
The New England Journal of Medicine|February 1, 2002
Bullous pemphigoid therapy -- think globally, act locallyRobert S Stern
NEJM Evidence|November 5, 2025
Oral Psoriasis Therapy - For Whom and at What Cost and Risk?Robert S Stern
Journal of the American Academy of Dermatology|January 24, 2012
The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective studyRobert S Stern,
Health News (Waltham, Mass.)|July 9, 2004
Questions & answers. Of all the treatments that promise to improve the appearance of aging skin, which ones have been medically proven to actually work?Robert S Stern
The New England Journal of Medicine|April 9, 2004
Clinical practice. Treatment of photoagingRobert S Stern
The Journal of Investigative Dermatology. Symposium Proceedings|April 16, 2004
Dermatologists and office-based care of dermatologic disease in the 21st centuryRobert S Stern
Pharmacoepidemiology and Drug Safety|January 13, 2005
Utilization of hospital and outpatient care for adverse cutaneous reactions to medicationsRobert S Stern
Pageof 7